We just received data on a new analyst forecast for $EXE. UBS gave a rating of 'Buy' for $EXE.
$EXE Analyst Ratings
Wall Street analysts have issued reports on $EXE in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 10/13/2025
- Jefferies issued a "Buy" rating on 10/03/2025
- Raymond James issued a "Strong Buy" rating on 09/11/2025
- Piper Sandler issued a "Overweight" rating on 08/14/2025
- Scotiabank issued a "Sector Outperform" rating on 07/11/2025
- Mizuho issued a "Outperform" rating on 07/01/2025
- Keybanc issued a "Overweight" rating on 06/13/2025
To track analyst ratings and price targets for $EXE, check out Quiver Quantitative's $EXE forecast page.
$EXE Price Targets
Multiple analysts have issued price targets for $EXE recently. We have seen 12 analysts offer price targets for $EXE in the last 6 months, with a median target of $136.0.
Here are some recent targets:
- Josh Silverstein from UBS set a target price of $131.0 on 10/13/2025
- Cameron Bean from Scotiabank set a target price of $150.0 on 10/09/2025
- Betty Jiang from Barclays set a target price of $136.0 on 10/07/2025
- Lloyd Byrne from Jefferies set a target price of $137.0 on 10/03/2025
- John Freeman from Raymond James set a target price of $150.0 on 09/11/2025
- Tim Rezvan from Keybanc set a target price of $127.0 on 09/03/2025
- Leo Mariani from Roth Capital set a target price of $98.0 on 08/18/2025
$EXE Insider Trading Activity
$EXE insiders have traded $EXE stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EXE stock by insiders over the last 6 months:
- DOMENIC J JR DELL'OSSO (President and CEO) purchased 2,500 shares for an estimated $239,650
- JOSHUA J. VIETS (EVP & COO) purchased 2,000 shares for an estimated $184,320
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
